A detailed history of Harrington Investments, Inc transactions in Danaher Corp stock. As of the latest transaction made, Harrington Investments, Inc holds 1,052 shares of DHR stock, worth $254,794. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,052
Previous 1,076 2.23%
Holding current value
$254,794
Previous $248,000 5.65%
% of portfolio
0.15%
Previous 0.16%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$224.58 - $256.19 $5,389 - $6,148
-24 Reduced 2.23%
1,052 $262,000
Q3 2023

Oct 19, 2023

BUY
$233.08 - $265.59 $12,120 - $13,810
52 Added 5.08%
1,076 $266,000
Q2 2023

Jul 20, 2023

BUY
$224.99 - $256.14 $38,248 - $43,543
170 Added 19.91%
1,024 $245,000
Q3 2022

Oct 19, 2022

SELL
$247.06 - $1507.4 $21,988 - $134,158
-89 Reduced 9.44%
854 $221,000
Q2 2022

Jul 22, 2022

BUY
$237.11 - $299.66 $17,546 - $22,174
74 Added 8.52%
943 $239,000
Q4 2021

Jan 21, 2022

SELL
$292.08 - $329.01 $181,089 - $203,986
-620 Reduced 41.64%
869 $286,000
Q3 2021

Oct 28, 2021

BUY
$272.21 - $332.43 $168,770 - $206,106
620 Added 71.35%
1,489 $453,000
Q2 2021

Aug 03, 2021

BUY
$225.08 - $271.69 $195,594 - $236,098
869 New
869 $233,000
Q3 2020

Oct 21, 2020

SELL
$177.16 - $215.33 $329,517 - $400,513
-1,860 Closed
0 $0
Q2 2020

Jul 21, 2020

SELL
$128.7 - $176.83 $51,479 - $70,732
-400 Reduced 17.7%
1,860 $329,000
Q4 2019

Feb 10, 2020

SELL
$133.47 - $153.48 $26,960 - $31,002
-202 Reduced 8.2%
2,260 $347,000
Q2 2019

Aug 07, 2019

BUY
$124.88 - $143.73 $2,497 - $2,874
20 Added 0.82%
2,462 $352,000
Q4 2017

Feb 01, 2018

BUY
$85.26 - $94.62 $208,204 - $231,062
2,442
2,442 $227,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $176B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Harrington Investments, Inc Portfolio

Follow Harrington Investments, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrington Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harrington Investments, Inc with notifications on news.